Advertisement

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke

Conference paper

Abstract

The logic of thrombolytic therapy includes the two-stage argument that thrombolytic agents recanalize occluded cerebral arteries and early reperfusion is followed by neurological improvement [1]. Intravenous infusion is simple and technically safe, but its efficiency may be low compared with intraarterial infusion because of agent dilution and passive delivery of the drug to the target thrombi through the bloodstream [1,2].

Keywords

Acute Ischemic Stroke Thrombolytic Therapy Thrombolytic Agent Hemorrhagic Transformation Intravenous Bolus Injection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mori E (1993) Safety and efficacy of fibrinolytic agents in acute ischemic stroke. Cerebrovasc Dis 3: 264–268CrossRefGoogle Scholar
  2. 2.
    del Zoppo GJ, Pessin MS, Mori E, Hacke W (1991) Thrombolytic intervention in acute thrombotic and embolic stroke. Semin Neurol 11: 368–384PubMedCrossRefGoogle Scholar
  3. 3.
    Yamaguchi T, Hayakawa T, Kikuchi H, Abe T (1990) Thrombolytic therapy in embolic and thrombotic cerebral infarction: a cooperative study. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer, Berlin Heidelberg New York, pp 161–167Google Scholar
  4. 4.
    Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marier JR (1992) Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administrated within 90 minutes. Stroke 23: 632–640PubMedCrossRefGoogle Scholar
  5. 5.
    Haley EC Jr, Levy DE, Brott TG, Sheppard GL, Wong MCW, Kongable GL, Torner JC, Marier JR (1992) Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administrated 91–180 minutes from onset. Stroke 23: 641–645PubMedCrossRefGoogle Scholar
  6. 6.
    von Kummer R, Hacke W (1992) Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23: 646–652CrossRefGoogle Scholar
  7. 7.
    del Zoppo. GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R Jr, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86PubMedCrossRefGoogle Scholar
  8. 8.
    Overgaard K, Sperling B, Boysen G, Pedersen H, Gam J, Ellemann K, Kane A, ArlienSöborg P, Olsen TS, Videbæk C, Knudsen JB (1993) Thrombolytic therapy in acute ischemic stroke. A Danish pilot study. Stroke 24: 1439–1446PubMedCrossRefGoogle Scholar
  9. 9.
    Baird AE, Donnan GA, Austin MC, Fitt GJ, Davis SM, McKay WJ (1994) Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography. Stroke 25: 79–85PubMedCrossRefGoogle Scholar
  10. 10.
    Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42: 976–982PubMedGoogle Scholar
  11. 11.
    Yamaguchi T, Hayakawa T, Kikuchi H, Japanese Thrombolysis Study Group (1993) Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 3: 269–272CrossRefGoogle Scholar
  12. 12.
    Haley EC Jr, Brott TG, Sheppard GL, Barsan W, Broderick J, Marier JR, Kongable GL, Spilker J, Massey S, Hansen CA, Torner JC, TPA Bridging Study Group (1993) Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke 24: 1000–1004PubMedCrossRefGoogle Scholar
  13. 13.
    del Zoppo GJ, Ferbert A, Otis S, Bruckmann H, Hacke W, Zyroff J, Harker LA, Zeumer H (1988) Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. Stroke 19: 307–313PubMedCrossRefGoogle Scholar
  14. 14.
    Zeumer H, Freitag HJ, Grzyka U, Neeunzig HP (1989) Local intra-arterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results. Neuroradiology 31: 336–340PubMedCrossRefGoogle Scholar
  15. 15.
    Theron J, Courtheoux P, Casasco A, Alachkar F, Notari F, Ganem F, Maiza D (1989) Local intraarterial fibrinolysis in the carotid territory. AJNR 10: 753–765PubMedGoogle Scholar
  16. 16.
    Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C (1993) Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (rt-PA). Neuroradiology 35: 159–162PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1995

Authors and Affiliations

  • E. Mori
    • 1
  1. 1.Clinical NeuroscienceHyogo Institute for Aging Brain and Cognitive DisordersHimeji, Hyogo, 670Japan

Personalised recommendations